Skip Navigation

Frank Gerberick Receives Award for Advancing Alternatives

November 24, 2014
Alternatives Research & Development Foundation

Frank Gerberick, a scientist at the Procter & Gamble Company, based in Cincinnati, Ohio, received the William and Eleanor Cave Award last week at a private reception in Bethesda, Maryland.

The Award was presented by the Alternatives Research & Development Foundation (ARDF) of Jenkintown, Pennsylvania, before a gathering of dozens of colleagues at the third Annual Meeting of the American Society for Cellular and Computational Toxicology (ASCCT).

ARDF President Sue Leary explained, “This recognition is for Frank Gerberick’s impressive career achievements in developing alternative test methods. He has been a real leader in the field.” Dr. Gerberick began his alternatives research in late 1980s, and in January 2014, European authorities accepted the Direct Peptide Reactivity Assay (DPRA), an alternative test method his team developed for skin sensitization. Over the years, he has been an author on over 160 scientific articles, and received numerous awards and honors for his work, including the Society of Toxicology’s Animal Welfare Award.

See full details here.

New ALTEX: 2/2018

ALTEX cover 51

Support ALTWEB, Make a Gift
Online Humane Science Course


Building a Better Epithelium: Breaking the Barrier to the Next Generation of Toxicity Testing
March 10, 2018
San Antonio, TX

SOT Satellite Meeting: Updates on Activities Related to 21st Century Toxicology and Related Efforts: Invited Presentations and Open Mic
March 15, 2018
San Antonio, TX

Social Housing Workshop
June 4-5, 2018
Beltsville, MD

2nd Pan-American Conference for Alternative Methods
August 23-24, 2018
Rio de Janeiro, Brazil 

Eurotox 2018
September 2-5, 2018
Brussels, Belgium

20th International Congress on In Vitro Toxicology (ESTIV2018)
October 15-18, 2018

More Meetings...